V(D)J recombination of antigen receptor gene segments in B and T cells is mediated by the lymphoid-specific proteins RAG1 and RAG2. Now, Ji et al. (2010) demonstrate how RAG1 and RAG2 use DNA sequence specificity and modified histones within chromatin to target specific loci for V(D)J recombination at different stages of lymphoid development.
How the pattern of gene expression in an individual cell type is established is a crucial question that has been extensively studied for over three decades. A combination of genetics and in vitro biochemistry led to the discovery of factors that are required for or influence initiation, elongation, and termination by RNA polymerase II (Pol II). More recently, mapping the binding of Pol II and its associated factors across the genomes of human, mouse, and the fruit fly Drosophila has provided a more global view of these events. Together, these studies refute the view that gene expression is controlled mainly by the selective initiation of transcription. Instead, most genes experience initiation, but only specific genes produce mRNAs. The elegant study by Rahl et al. (2010) in this issue clearly demonstrates that regulation of the elongation phase of transcription plays a major role in gene expression in mouse embryonic stem (ES) cells.
In 1992, a model for the control of Pol II elongation was proposed that incorporated both negative factors that trap engaged polymerases in promoter-proximal positions and positive factors that selectively promote productive elongation (Marshall and Price, 1992) . Since then, specific positive and negative factors have been identified . As indicated in Figure 1 , two negative factors, DRB-sensitivity inducing factor (DSIF) and negative elongation factor (NELF), associate with the elongation complex and help to pause Pol II in a position proximal to promoters. Positive transcription elongation factor b (P-TEFb) phosphorylates the negative factors and Pol II, which causes the elongation complex to enter productive elongation. At the heart of this model are the paused polymerases that are poised for activation.
Although poised polymerases were initially discovered on a number of specific genes , evidence is mounting that they are prevalent across mammalian and fruit fly genomes. Using a combination of chromatin immunoprecipitation and microarray analysis (ChIP-chip), large peaks of Pol II have been mapped to promoter-proximal regions in Drosophila and humans (Guenther et al., 2007; Muse et al., 2007; Zeitlinger et al., 2007) . The study by Rahl and colleagues extends this using chromatin immunoprecipitation followed by sequencing (ChIP-seq) to map the location of Pol II, DSIF, and NELF in mouse ES cells. They find that most genes have Pol II in promoterproximal positions and that both DSIF and NELF map to the same locations, consistent with the notion that these polymerases are engaged in transcription. DSIF, but not NELF, maps with Pol II at highly transcribed genes and downstream of their poly(A) sites.
The results described by Rahl et al. provide strong evidence that activation of transcription is accomplished at least in part at the level of elongation. First, they show that P-TEFb is generally required for transcription of mRNAs by performing Pol II ChIP-seq on mouse ES cells treated with the P-TEFb inhibitor flavopiridol. Following treatment only poised polymerases remained. They confirm that P-TEFb interacts with c-Myc in mouse ES cells and then show that almost all genes targeted by c-Myc experience elongation (Figure 1) . Finally, they find that treatment of cells with a compound that inhibits c-Myc function and reduces the expression of mRNAs induced by c-Myc causes a reduction in elongation but does not affect polymerase pausing at the affected genes. Inhibition of c-Myc mimics flavopiridol treatment on the c-Myc-induced genes. In contrast, reduction of Oct4, a The genome-wide mapping presented in this issue by Rahl et al. (2010) demonstrates how the transcription factor c-Myc interfaces with the machinery that controls RNA polymerase II elongation. These findings account for the ability of c-Myc to activate the expression of a large number of genes that promote rapid proliferation. After initiation, RNA polymerase II (Pol II) pauses in a promoter-proximal position due to the action of DSIF and NELF. These polymerases are located on most genes and are poised for entry into productive elongation that is triggered by the phosphorylation of DSIF and NELF as well as the C-terminal domain (CTD) of Pol II by P-TEFb. c-Myc bound to nearby DNA recruits P-TEFb to function on a large subset of genes in mouse embryonic stem cells.
transcription factor important for mouse ES cells, does not have the same effect on Oct4-induced genes. Instead, in that case, the presence of poised and elongating Pol II are both reduced. In the larger context, poised polymerase appears to be one of the major features of higher eukaryotic genomes, and how it is employed is now becoming clear. Although there was some reluctance to believe that genomes were loaded with engaged polymerases that were not elongating for the most part, strong evidence in support of this notion has come from the sequencing of nascent human and Drosophila RNAs (Core et al., 2008; Nechaev et al., 2010) and from studies showing association of elongation factors with the poised Pol II (Gilchrist et al., 2008; Rahl et al., 2010) . Extensive analysis of the heat shock genes in Drosophila by the lab of John Lis implicates poised polymerase in rapid gene activation . In Drosophila, poised polymerases allow synchronous rather than stochastic expression of genes induced during development (Boettiger and Levine, 2009 ). Interestingly, when NELF is knocked down in Drosophila it causes a reduction or loss of the poised Pol II on some genes, and this leads to reduced gene expression and a reduction in initiation (Gilchrist et al., 2008) . Evidently, the poised Pol II is needed to hold some promoters in an open state. In the Rahl et al. study knockdown of NELF has a similar although more modest effect on the distribution of Pol II. By comparison, knockdown of DSIF leads to a more dramatic increase in Pol II downstream of the promoters of actively transcribed genes.
It is now time to attain a better understanding of the mechanisms involved in generating poised Pol II and how it is released into productive elongation. Although it is likely that some factors involved in generating poised polymerases remain to be discovered, there is already an abundance of evidence pointing toward selective utilization of P-TEFb as the key to achieving genespecific activation. As demonstrated by Rahl et al., recruitment of P-TEFb is strongly implicated in c-Myc function. Looking to the future, it may be possible to develop compounds targeting the step in transcriptional elongation regulated by c-Myc/P-TEFb that might be effective in halting the proliferation of cancer cells.
The variable domains of antigen receptors are encoded by exons assembled during B and T lymphocyte development from component V, D, and J gene segments. This assembly process, called V(D)J recombination, depends on a series of site-specific DNA recombination reactions and is orchestrated by the RAG1 and RAG2 proteins, which are coexpressed exclusively by lymphoid cells. RAG1 and RAG2 recognize the rearranging V, D, and J gene segments and initiate recombination by introducing double-strand breaks in the DNA (Bassing et al., 2002) . Although RAG1 and RAG2 form a multimeric complex in solution, it is unclear in what form they initially recognize and bind to DNA in vivo. In this issue of Cell, Schatz and
